A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia (CIN2/3)

Autor: Trimble, C.L., Levinson, K., Maldonado, L., Donovan, M., Clark, K.T., Fu, J., Shay, M.E., Sauter, M.E., Sanders, S., Frantz, P.S., Plesa, M.
Zdroj: In Gynecologic Oncology October 2020 159 Supplement 1:37-37
Databáze: ScienceDirect